These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 17803521

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.
    Liu WG, Lu GQ, Li B, Chen SD.
    Parkinsonism Relat Disord; 2007 Mar; 13(2):77-88. PubMed ID: 16963309
    [Abstract] [Full Text] [Related]

  • 3. Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease.
    Sharma R, McMillan CR, Tenn CC, Niles LP.
    Brain Res; 2006 Jan 12; 1068(1):230-6. PubMed ID: 16375867
    [Abstract] [Full Text] [Related]

  • 4. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, Hayase H, Hamada H, Borlongan CV, Date I.
    Brain Res; 2005 Aug 16; 1053(1-2):10-8. PubMed ID: 16045899
    [Abstract] [Full Text] [Related]

  • 5. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
    Bouchez G, Sensebé L, Vourc'h P, Garreau L, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard JC, Chalon S.
    Neurochem Int; 2008 Jun 16; 52(7):1332-42. PubMed ID: 18372079
    [Abstract] [Full Text] [Related]

  • 6. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
    Gu S, Huang H, Bi J, Yao Y, Wen T.
    Brain Res; 2009 Feb 27; 1257():1-9. PubMed ID: 19111525
    [Abstract] [Full Text] [Related]

  • 7. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR.
    Brain Res; 2009 Jun 18; 1276():39-49. PubMed ID: 19389387
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
    Jensen P, Pedersen EG, Zimmer J, Widmer HR, Meyer M.
    Brain Res; 2008 Jul 07; 1218():13-20. PubMed ID: 18513704
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
    Quinn M, Mukhida K, Sadi D, Hong M, Mendez I.
    Eur J Neurosci; 2008 Jan 07; 27(1):43-52. PubMed ID: 18093176
    [Abstract] [Full Text] [Related]

  • 14. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
    Niles LP, Armstrong KJ, Rincón Castro LM, Dao CV, Sharma R, McMillan CR, Doering LC, Kirkham DL.
    BMC Neurosci; 2004 Oct 28; 5():41. PubMed ID: 15511288
    [Abstract] [Full Text] [Related]

  • 15. Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease.
    Harvey BK, Mark A, Chou J, Chen GJ, Hoffer BJ, Wang Y.
    Brain Res; 2004 Oct 01; 1022(1-2):88-95. PubMed ID: 15353217
    [Abstract] [Full Text] [Related]

  • 16. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M, Wang XJ, Zhang YH, Lu GQ, Liang L, Xu JY, Chen SD.
    Brain Res; 2007 Apr 20; 1142():206-16. PubMed ID: 17336273
    [Abstract] [Full Text] [Related]

  • 17. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    J Neurosci Methods; 2005 May 15; 144(1):35-45. PubMed ID: 15848237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.
    Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I.
    Eur J Neurosci; 2004 Mar 15; 19(6):1494-504. PubMed ID: 15066146
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
    Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I.
    Behav Brain Res; 2004 May 05; 151(1-2):303-12. PubMed ID: 15084446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.